BioNTech Rna Pharmaceuticals GmbH
Records under this name other than the patents BioNTech Rna Pharmaceuticals GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Back to BioNTech Rna Pharmaceuticals GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,020,477 | RNA Vaccines now held by BioNTech SE In force · Medium confidence | In force | Medium confidence | |
| US 10,485,884 | RNA Formulation for Immunotherapy now held by BioNTech SE In force · High confidence | In force | High confidence | |
| US 10,738,355 | Individualized Vaccines for Cancer now held by BioNTech SE In force · High confidence | In force | High confidence | |
| US 11,248,264 | Individualized Vaccines for Cancer now held by BioNTech SE In force · High confidence | In force | High confidence | |
| US 9,295,717 | Vaccine Composition Comprising 5'-CAP Modified RNA now held by BioNTech SE In force · High confidence | In force | High confidence | |
| US 10,729,784 | Method for Cellular RNA Expression now held by BioNTech SE In force · High confidence | In force | High confidence | |
| US 10,207,009 | Method for Cellular RNA Expression now held by BioNTech SE In force · High confidence | In force | High confidence | |
| US 11,559,587 | RNA Formulation for Immunotherapy now held by BioNTech SE In force · High confidence | In force | High confidence | |
| US 10,717,780 | Agents for Treatment of Claudin Expressing Cancer Diseases now held by Astellas Pharma Inc. In force · High confidence | In force | High confidence | |
| US 10,155,031 | Individualized Vaccines for Cancer now held by BioNTech SE In force · High confidence | In force | High confidence |